HL
Harding Loevner’s Core Laboratories CLB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-124,004
| Closed | -$2.73M | – | 72 |
|
|
2023
Q1 | $2.73M | Buy |
124,004
+4,417
| +4% | +$97.4K | 0.02% | 71 |
|
|
2022
Q4 | $2.42M | Sell |
119,587
-3,635
| -3% | -$73.7K | 0.01% | 79 |
|
|
2022
Q3 | $1.66M | Buy |
123,222
+7,543
| +7% | +$102K | 0.01% | 76 |
|
|
2022
Q2 | $2.29M | Buy |
115,679
+3,691
| +3% | +$73.1K | 0.01% | 76 |
|
|
2022
Q1 | $2.71M | Buy |
111,988
+8,453
| +8% | +$204K | 0.01% | 79 |
|
|
2021
Q4 | $2.31M | Hold |
103,535
| – | – | 0.01% | 81 |
|
|
2021
Q3 | $2.87M | Buy |
103,535
+1,691
| +2% | +$46.9K | 0.01% | 81 |
|
|
2021
Q2 | $3.97M | Buy |
101,844
+11,373
| +13% | +$443K | 0.01% | 78 |
|
|
2021
Q1 | $2.61M | Buy |
90,471
+944
| +1% | +$27.2K | 0.01% | 81 |
|
|
2020
Q4 | $2.37M | Buy |
89,527
+5,375
| +6% | +$142K | 0.01% | 73 |
|
|
2020
Q3 | $1.28M | Sell |
84,152
-1,064
| -1% | -$16.2K | ﹤0.01% | 105 |
|
|
2020
Q2 | $1.73M | Sell |
85,216
-87,650
| -51% | -$1.78M | 0.01% | 72 |
|
|
2020
Q1 | $1.79M | Buy |
172,866
+29,783
| +21% | +$308K | 0.01% | 79 |
|
|
2019
Q4 | $5.39M | Sell |
143,083
-14,736
| -9% | -$555K | 0.02% | 72 |
|
|
2019
Q3 | $7.36M | Buy |
157,819
+70,749
| +81% | +$3.3M | 0.03% | 70 |
|
|
2019
Q2 | $4.55M | Buy |
87,070
+44,088
| +103% | +$2.3M | 0.02% | 71 |
|
|
2019
Q1 | $2.96M | Buy |
42,982
+10,249
| +31% | +$707K | 0.01% | 71 |
|
|
2018
Q4 | $1.95M | Buy |
32,733
+21,020
| +179% | +$1.25M | 0.01% | 72 |
|
|
2018
Q3 | $1.36M | Sell |
11,713
-849
| -7% | -$98.4K | 0.01% | 72 |
|
|
2018
Q2 | $1.59M | Buy |
+12,562
| New | +$1.59M | 0.01% | 70 |
|
|
2016
Q3 | – | Sell |
-15
| Closed | -$2K | – | 89 |
|
|
2016
Q2 | $2K | Hold |
15
| – | – | ﹤0.01% | 84 |
|
|
2016
Q1 | $2K | Buy |
15
+14
| +1,400% | +$1.87K | ﹤0.01% | 86 |
|
|
2015
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 103 |
|